USP Draft Medicare Formulary Update Adds Nine Classes, Targeted Cancer Drugs
Executive Summary
Released Oct. 1, the draft update to the USP Medicare Model Formulary Guidelines includes several new classes formed to accommodate novel therapies approved in the last three years, including targeted cancer drugs.